Combined eirect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model [2]

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 4043-4044

  Yuste, J ^a   Fenoll, A ^a   Casal, J ^a   Gimenez M J ^b   Aguilar, L ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBODY; HYPERIMMUNE GLOBULIN; BACTERIUM ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FOLLOW UP; IMMUNIZATION; IMMUNOTHERAPY; LETTER; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SERUM; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; IMMUNOLOGY; METHODOLOGY; PASSIVE IMMUNIZATION;

AMOXICILLIN; ANIMALS; ANTIBODIES, BACTERIAL; FEMALE; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED BALB C; PNEUMOCOCCAL INFECTIONS;

EID: 0036896464     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.4043-4044.2002     Document Type: Letter

References (3)

1. Casal, J., L. Aguilar, I. Jado, J. Yuste, M. J. Giménez, J. Prieto, and A. Fenoll. 2002. Effects of specific antibodies against Streptococcuspneumoniae on pharmacodynamic parameters of β-lactams in a mouse sepsis model. Antimicrob. Agents Chemother. 46:1340-1344.
2. Yuste, J., M. J. Giménez, I. Jado, A. Fenoll, L. Aguilar, and J. Casal. 2001. Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-inhibitory concentrations of amoxicillin. J. Antimicrob. Chemother. 48:594-595.
3. Yuste, J., I. Jado, M. J. Giménez, L. Aguilar, F. Molero, A. Fenoll, and J. Casal. 2002. Modification of bacteraemia by specific antibodies and relation with mortality in a pneumococcal mouse sepsis model. Clin. Exp. Immunol 128:411-415.